Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2016

25.07.2016 | Original Article

Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis

verfasst von: Feifei Hou, Xingshun Qi, Xiaozhong Guo

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Hepatic hydrothorax (HH) is a serious complication of end-stage liver diseases, which is associated with poor survival. There is no consensus regarding the treatment of HH.

Aim

To evaluate the effectiveness and safety of pleurodesis for HH in a systematic review with meta-analysis.

Methods

All relevant papers were searched on the EMBASE and PubMed databases. As for the data from the eligible case reports, the continuous data were expressed as the median (range) and the categorical data were expressed as the frequency (percentage). As for the data from the eligible case series, the rates of complete response and complications were pooled. The proportions with 95 % confidence intervals (CIs) were calculated by using random-effect model.

Results

Twenty case reports including 26 patients and 13 case series including 180 patients were eligible. As for the case reports, the median age was 55 years (range 7–78) and 15 patients were male. The prevalence of ascites was 76 % (19/25). Seventeen (65.38 %) patients responded favorably to pleurodesis. As for the case series, the mean age was 51.5–63.0 years and 83 patients were male. The pooled prevalence of ascites was 90 % (95 % CI 81–97 %) in 7 studies including 71 patients. The complete response rate after pleurodesis was reported in all studies, and the pooled rate was 72 % (95 % CI 65–79 %). Complications related to pleurodesis were reported in 6 studies including 63 patients, and the pooled rate was 82 % (95 % CI 66–94 %).

Conclusion

Pleurodesis may be a promising treatment for HH, but carries a high rate of complications.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20:271–279.CrossRefPubMed Cardenas A, Kelleher T, Chopra S. Review article: hepatic hydrothorax. Aliment Pharmacol Ther. 2004;20:271–279.CrossRefPubMed
3.
Zurück zum Zitat Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999;107:262–267.CrossRefPubMed Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999;107:262–267.CrossRefPubMed
4.
Zurück zum Zitat Poinso R, Chanas P. Pleural manifestations of liver cirrhosis. La Presse Medi. 1958;66:1106–1108. Poinso R, Chanas P. Pleural manifestations of liver cirrhosis. La Presse Medi. 1958;66:1106–1108.
5.
Zurück zum Zitat Sivanathan V, Kittner JM, Sprinzl MF, et al. Etiology and complications of liver cirrhosis: data from a German centre. Dtsch Med Wochenschr. 2014;139:1758–1762.CrossRefPubMed Sivanathan V, Kittner JM, Sprinzl MF, et al. Etiology and complications of liver cirrhosis: data from a German centre. Dtsch Med Wochenschr. 2014;139:1758–1762.CrossRefPubMed
6.
Zurück zum Zitat Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine. 2014;93:135–142.CrossRefPubMedPubMedCentral Badillo R, Rockey DC. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature. Medicine. 2014;93:135–142.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Hou F, Qi X, Ning Z, et al. Prevalence, risk factors, and in-hospital outcome of pleural effusion in liver cirrhosis: a retrospective observational study. Int J Clin Exp Med. 2016;9:3265–3279. Hou F, Qi X, Ning Z, et al. Prevalence, risk factors, and in-hospital outcome of pleural effusion in liver cirrhosis: a retrospective observational study. Int J Clin Exp Med. 2016;9:3265–3279.
8.
Zurück zum Zitat Liu WL, Kuo PH, Ku SC, Huang PM, Yang PC. Impact of therapeutic interventions on survival of patients with hepatic hydrothorax. J Formosan Med Assoc Taiwan yi zhi. 2010;109:582–588.CrossRefPubMed Liu WL, Kuo PH, Ku SC, Huang PM, Yang PC. Impact of therapeutic interventions on survival of patients with hepatic hydrothorax. J Formosan Med Assoc Taiwan yi zhi. 2010;109:582–588.CrossRefPubMed
9.
Zurück zum Zitat Ibi T, Koizumi K, Hirata T, Mikami I, Hisayoshi T, Shimizu K. Diaphragmatic repair of two cases of hepatic hydrothorax using video-assisted thoracoscopic surgery. Gen Thoracic Cardiovasc Surg. 2008;56:229–232.CrossRef Ibi T, Koizumi K, Hirata T, Mikami I, Hisayoshi T, Shimizu K. Diaphragmatic repair of two cases of hepatic hydrothorax using video-assisted thoracoscopic surgery. Gen Thoracic Cardiovasc Surg. 2008;56:229–232.CrossRef
10.
Zurück zum Zitat Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thoracic Cardiovasc Surg. 2005;130:141–145.CrossRef Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thoracic Cardiovasc Surg. 2005;130:141–145.CrossRef
11.
Zurück zum Zitat Frazer IH, Lichtenstein M, Andrews JT. Pleuroperitoneal effusion without ascites. Med J Aust. 1983;2:520–521.PubMed Frazer IH, Lichtenstein M, Andrews JT. Pleuroperitoneal effusion without ascites. Med J Aust. 1983;2:520–521.PubMed
12.
Zurück zum Zitat Ajmi S, Hassine H, Arifa N, et al. Large diaphragmatic defect as the cause of hydrothorax in a cirrhotic patient: demonstration with peritoneal scintigraphy and magnetic resonance imaging. Magn Reson Imaging. 2004;22:431–433.CrossRefPubMed Ajmi S, Hassine H, Arifa N, et al. Large diaphragmatic defect as the cause of hydrothorax in a cirrhotic patient: demonstration with peritoneal scintigraphy and magnetic resonance imaging. Magn Reson Imaging. 2004;22:431–433.CrossRefPubMed
13.
Zurück zum Zitat Matono T, Koda M, Murawaki Y. Right diaphragmatic defect in hepatic hydrothorax exposed by contrast-enhanced ultrasonography after radiofrequency ablation. Hepatology. 2012;56:784–785.CrossRefPubMed Matono T, Koda M, Murawaki Y. Right diaphragmatic defect in hepatic hydrothorax exposed by contrast-enhanced ultrasonography after radiofrequency ablation. Hepatology. 2012;56:784–785.CrossRefPubMed
14.
Zurück zum Zitat Huang PM, Han YY, Kuo SW, Lee YC. Color Doppler ultrasonography in detecting transdiaphragmatic flow of hepatic hydrothorax: correlation with thoracoscopic findings. J Thoracic Cardiovasc Surg. 2009;138:1251–1252.CrossRef Huang PM, Han YY, Kuo SW, Lee YC. Color Doppler ultrasonography in detecting transdiaphragmatic flow of hepatic hydrothorax: correlation with thoracoscopic findings. J Thoracic Cardiovasc Surg. 2009;138:1251–1252.CrossRef
16.
Zurück zum Zitat Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol. 2002;13:385–390.CrossRefPubMed Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Interv Radiol. 2002;13:385–390.CrossRefPubMed
17.
Zurück zum Zitat Ditah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: a systematic review and cumulative meta-analysis. World J Hepatol. 2015;7:1797–1806.CrossRefPubMedPubMedCentral Ditah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: a systematic review and cumulative meta-analysis. World J Hepatol. 2015;7:1797–1806.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13:529–534.CrossRefPubMed Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001;13:529–534.CrossRefPubMed
19.
Zurück zum Zitat Cardenas A, Arroyo V. Management of ascites and hepatic hydrothorax. Best Pract Res Clin Gastroenterol. 2007;21:55–75.CrossRefPubMed Cardenas A, Arroyo V. Management of ascites and hepatic hydrothorax. Best Pract Res Clin Gastroenterol. 2007;21:55–75.CrossRefPubMed
20.
Zurück zum Zitat Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulmonary Med. 2014;20:352–357.CrossRef Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulmonary Med. 2014;20:352–357.CrossRef
21.
22.
Zurück zum Zitat Alba D, Molina F, Ripoll MM, Castillo P, Lizasoain J, Vázquez JJ. Pleuroperitoneal shunt in the treatment of pleural effusion associated with cirrhosis. Anal Med Intern. (Madrid, Spain: 1984) 1993;10:604–606. Alba D, Molina F, Ripoll MM, Castillo P, Lizasoain J, Vázquez JJ. Pleuroperitoneal shunt in the treatment of pleural effusion associated with cirrhosis. Anal Med Intern. (Madrid, Spain: 1984) 1993;10:604–606.
23.
Zurück zum Zitat Canto A, Arnau A, Moya J, Ferrer G. Talcum pleurodesis in massive recurrent pleural effusions in liver cirrhosis. Res Surg. 1989;1:142–144. Canto A, Arnau A, Moya J, Ferrer G. Talcum pleurodesis in massive recurrent pleural effusions in liver cirrhosis. Res Surg. 1989;1:142–144.
24.
Zurück zum Zitat Colombo A, Boncinelli L, Pinzi M, Ideo G. A new therapeutic approach in hepatic hydrothorax. Miner Med. 1992;83:219–222. Colombo A, Boncinelli L, Pinzi M, Ideo G. A new therapeutic approach in hepatic hydrothorax. Miner Med. 1992;83:219–222.
25.
Zurück zum Zitat Drouhin F, Fischer D, Law Koune JD, Boiteau R, Tenaillon A, Labayle D. Treatment of hydrothorax in liver cirrhosis with chemical pleurodesis and continuous positive airway pressure. Preliminary results [9]. Gastroenterol Clin Biol. 1991;15:271–272.PubMed Drouhin F, Fischer D, Law Koune JD, Boiteau R, Tenaillon A, Labayle D. Treatment of hydrothorax in liver cirrhosis with chemical pleurodesis and continuous positive airway pressure. Preliminary results [9]. Gastroenterol Clin Biol. 1991;15:271–272.PubMed
26.
Zurück zum Zitat Lorang B, Steinbach G, Pierron A, Chopin J. Respiratory failure by massive and recurrent hydrothorax in a patient with hepatic cirrhosis. Report of a case. Converg Med. 1984;3:549–553. Lorang B, Steinbach G, Pierron A, Chopin J. Respiratory failure by massive and recurrent hydrothorax in a patient with hepatic cirrhosis. Report of a case. Converg Med. 1984;3:549–553.
27.
Zurück zum Zitat Matsuda M, Tachibana Y, Ogino H, Satomura Y, Unoura M. Treatment for intractable hepatic hydrothorax with nasal continuous positive airway pressure (CPAP) and chemical pleurodesis. Acta Hepatol Japonica. 1998;39:914–918.CrossRef Matsuda M, Tachibana Y, Ogino H, Satomura Y, Unoura M. Treatment for intractable hepatic hydrothorax with nasal continuous positive airway pressure (CPAP) and chemical pleurodesis. Acta Hepatol Japonica. 1998;39:914–918.CrossRef
28.
Zurück zum Zitat Vignoli R, Di Donato C, Tramaloni C, et al. Hepatic hydrothorax: description of a case resolved with pleurodesis with sterile talc. Giornale Clin Med. 1987;68:585–587. Vignoli R, Di Donato C, Tramaloni C, et al. Hepatic hydrothorax: description of a case resolved with pleurodesis with sterile talc. Giornale Clin Med. 1987;68:585–587.
29.
Zurück zum Zitat Falchuk KR, Jacoby I, Colucci WS, Rybak ME. Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis. A new approach to treatment. Gastroenterology. 1977;72:319–321.PubMed Falchuk KR, Jacoby I, Colucci WS, Rybak ME. Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis. A new approach to treatment. Gastroenterology. 1977;72:319–321.PubMed
30.
Zurück zum Zitat Chu CH, Kao CR, Shih SC, et al. Hepatic hydrothorax: clinical experience and analysis. Gastroenterol J Taiwan. 1996;13:171–178. Chu CH, Kao CR, Shih SC, et al. Hepatic hydrothorax: clinical experience and analysis. Gastroenterol J Taiwan. 1996;13:171–178.
31.
Zurück zum Zitat Kim HJ, Cho YK, Kim BI. Chemical pleurodesis for the management of symptomatic hepatic hydrothorax. Hep Intl. 2011;5:343. Kim HJ, Cho YK, Kim BI. Chemical pleurodesis for the management of symptomatic hepatic hydrothorax. Hep Intl. 2011;5:343.
32.
Zurück zum Zitat Kottam R, Shah N, Malhotra A, Spira R, Depasquale J. Hepatic hydrothorax without ascites. Am J Gastroenterol. 2010;105:S283. Kottam R, Shah N, Malhotra A, Spira R, Depasquale J. Hepatic hydrothorax without ascites. Am J Gastroenterol. 2010;105:S283.
33.
Zurück zum Zitat Ajmi S, Hassine H, Guezguez M, et al. Isotopic exploration of hepatic hydrothorax: ten cases. Gastroenterol Clin Biol. 2004;28:462–466.CrossRefPubMed Ajmi S, Hassine H, Guezguez M, et al. Isotopic exploration of hepatic hydrothorax: ten cases. Gastroenterol Clin Biol. 2004;28:462–466.CrossRefPubMed
35.
Zurück zum Zitat Boin IF, Silva AM, Leonardi LS. Chemical pleurodesis for hepatic hydrothorax. Arq Gastroenterol. 2001;38:125–128.CrossRefPubMed Boin IF, Silva AM, Leonardi LS. Chemical pleurodesis for hepatic hydrothorax. Arq Gastroenterol. 2001;38:125–128.CrossRefPubMed
36.
Zurück zum Zitat Conklin LD, Estrera AL, Weiner MA, Reardon PR, Reardon MJ. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg. 2000;69:609–611.CrossRefPubMed Conklin LD, Estrera AL, Weiner MA, Reardon PR, Reardon MJ. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg. 2000;69:609–611.CrossRefPubMed
37.
Zurück zum Zitat Doraiswamy V, Riar S, Shrestha P, et al. Hepatic hydrothorax without any evidence of ascites. Sci World J. 2011;11:X587–X591.CrossRef Doraiswamy V, Riar S, Shrestha P, et al. Hepatic hydrothorax without any evidence of ascites. Sci World J. 2011;11:X587–X591.CrossRef
38.
Zurück zum Zitat Fujii T, Inoue S, Sugimoto H, Takeda S, Nakao A. Two cases of refractory hepatic hydrothorax treated successfully with transjugular intrahepatic portosystemic shunt. Jpn J Gastroenterol Surg. 2006;39:464–469.CrossRef Fujii T, Inoue S, Sugimoto H, Takeda S, Nakao A. Two cases of refractory hepatic hydrothorax treated successfully with transjugular intrahepatic portosystemic shunt. Jpn J Gastroenterol Surg. 2006;39:464–469.CrossRef
39.
Zurück zum Zitat Fujino T, Tomimatsu M, Chishima K, et al. A case of hepatic hydrothorax who was diagnosed by intraperitoneal indocyanine green (ICG) injection and recovered through chemical pleurodesis. J Tokyo Women’s Med College. 1992;62:1620–1625. Fujino T, Tomimatsu M, Chishima K, et al. A case of hepatic hydrothorax who was diagnosed by intraperitoneal indocyanine green (ICG) injection and recovered through chemical pleurodesis. J Tokyo Women’s Med College. 1992;62:1620–1625.
40.
Zurück zum Zitat Goto T, Oyamada Y, Hamaguchi R, et al. Remission of hepatic hydrothorax after OK-432 pleurodesis. Ann Thoracic Cardiovasc Surg. 2011;17:208–211.CrossRef Goto T, Oyamada Y, Hamaguchi R, et al. Remission of hepatic hydrothorax after OK-432 pleurodesis. Ann Thoracic Cardiovasc Surg. 2011;17:208–211.CrossRef
41.
Zurück zum Zitat Haitjema TJ, De Maat CEM. Pleural effusion without ascites in a patient with cirrhosis. Neth J Med. 1994;44:207–209.PubMed Haitjema TJ, De Maat CEM. Pleural effusion without ascites in a patient with cirrhosis. Neth J Med. 1994;44:207–209.PubMed
42.
Zurück zum Zitat Haskal ZJ, Zuckerman J. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest. 1994;106:1293–1295.CrossRefPubMed Haskal ZJ, Zuckerman J. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement. Chest. 1994;106:1293–1295.CrossRefPubMed
43.
Zurück zum Zitat Hsu KH, Tsai YF, Chiu NT, Chen LW, Lai WW. Thoracoscopic treatment of hepatic hydrothorax without ascites: a case report. Formosan J Surg. 2003;36:203–206. Hsu KH, Tsai YF, Chiu NT, Chen LW, Lai WW. Thoracoscopic treatment of hepatic hydrothorax without ascites: a case report. Formosan J Surg. 2003;36:203–206.
44.
Zurück zum Zitat Ikard RW, Sawyers JL. Persistent hepatic hydrothorax after peritoneojugular shunt. Arch Surg. 1980;115:1125–1127.CrossRefPubMed Ikard RW, Sawyers JL. Persistent hepatic hydrothorax after peritoneojugular shunt. Arch Surg. 1980;115:1125–1127.CrossRefPubMed
45.
Zurück zum Zitat Lin CC, Wu JW, Chang SC, et al. Resolution of refractory hepatic hydrothorax after chemical pleurodesis with minocycline. Chin Med J (Taipei). 2000;63:704–709. Lin CC, Wu JW, Chang SC, et al. Resolution of refractory hepatic hydrothorax after chemical pleurodesis with minocycline. Chin Med J (Taipei). 2000;63:704–709.
48.
Zurück zum Zitat Pop CM, Gherasim RM, Dumitrascu DL. Hydrothorax without ascites in liver cirrhosis. Rom J Gastroenterol. 2003;12:315–317.PubMed Pop CM, Gherasim RM, Dumitrascu DL. Hydrothorax without ascites in liver cirrhosis. Rom J Gastroenterol. 2003;12:315–317.PubMed
49.
Zurück zum Zitat Saito R, Rai T, Saito H, et al. Two cases of intractable hepatic hydrothorax successfully treated with nasal CPAP. Nihon Shokakibyo Gakkai Zasshi. 2006;103:1146–1151.PubMed Saito R, Rai T, Saito H, et al. Two cases of intractable hepatic hydrothorax successfully treated with nasal CPAP. Nihon Shokakibyo Gakkai Zasshi. 2006;103:1146–1151.PubMed
50.
Zurück zum Zitat Shirota Y, Kakinoki K, Wakabayashi T, Waseda R, Imai T. A case of intractable hepatic hydrothorax successfully treated by chemical pleurodesis after spontaneous bacterial empyema. Acta Hepatol Japonica. 2007;48:65–70.CrossRef Shirota Y, Kakinoki K, Wakabayashi T, Waseda R, Imai T. A case of intractable hepatic hydrothorax successfully treated by chemical pleurodesis after spontaneous bacterial empyema. Acta Hepatol Japonica. 2007;48:65–70.CrossRef
51.
Zurück zum Zitat Sira MM, Behairy Bel S, Bakir RM, El-Hagaly MA, Sira AM. Hepatic hydrothorax in the absence of ascites in a child with autoimmune hepatitis: successful management with octreotide and pleurodesis. Turk J Gastroenterol. 2013;24:174–183.CrossRefPubMed Sira MM, Behairy Bel S, Bakir RM, El-Hagaly MA, Sira AM. Hepatic hydrothorax in the absence of ascites in a child with autoimmune hepatitis: successful management with octreotide and pleurodesis. Turk J Gastroenterol. 2013;24:174–183.CrossRefPubMed
52.
Zurück zum Zitat Temes RT, Davis MS, Follis FM, Pett SB Jr, Wernly JA. Videothoracoscopic treatment of hepatic hydrothorax. Ann Thorac Surg. 1997;64:1468–1469.CrossRefPubMed Temes RT, Davis MS, Follis FM, Pett SB Jr, Wernly JA. Videothoracoscopic treatment of hepatic hydrothorax. Ann Thorac Surg. 1997;64:1468–1469.CrossRefPubMed
53.
Zurück zum Zitat Assouad J, Barthes Fle P, Shaker W, Souilamas R, Riquet M. Recurrent pleural effusion complicating liver cirrhosis. Ann Thorac Surg. 2003;75:986–989.CrossRefPubMed Assouad J, Barthes Fle P, Shaker W, Souilamas R, Riquet M. Recurrent pleural effusion complicating liver cirrhosis. Ann Thorac Surg. 2003;75:986–989.CrossRefPubMed
54.
Zurück zum Zitat de Campos JRM, Filho LO, de Campos Werebe E, et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest. 2000;118:13–17.CrossRef de Campos JRM, Filho LO, de Campos Werebe E, et al. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax. Chest. 2000;118:13–17.CrossRef
55.
Zurück zum Zitat Cerfolio RJ, Bryant AS. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg. 2006;82:457–459.CrossRefPubMed Cerfolio RJ, Bryant AS. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg. 2006;82:457–459.CrossRefPubMed
56.
Zurück zum Zitat Ferrante D, Arguedas MR, Cerfolio RJ, Collins BG, Van Leeuwen DJ. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol. 2002;97:3172–3175.CrossRefPubMed Ferrante D, Arguedas MR, Cerfolio RJ, Collins BG, Van Leeuwen DJ. Video-assisted thoracoscopic surgery with talc pleurodesis in the management of symptomatic hepatic hydrothorax. Am J Gastroenterol. 2002;97:3172–3175.CrossRefPubMed
57.
Zurück zum Zitat Lee WJ, Kim HJ, Park JH, et al. Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis. Korean J Hepatol. 2011;17:292–298.CrossRefPubMedPubMedCentral Lee WJ, Kim HJ, Park JH, et al. Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis. Korean J Hepatol. 2011;17:292–298.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Liu WL, Kuo PH, Ku SC, Huang PM, Yang PC. Impact of therapeutic interventions on survival of patients with hepatic hydrothorax. J Formos Med Assoc. 2010;109:582–588.CrossRefPubMed Liu WL, Kuo PH, Ku SC, Huang PM, Yang PC. Impact of therapeutic interventions on survival of patients with hepatic hydrothorax. J Formos Med Assoc. 2010;109:582–588.CrossRefPubMed
59.
Zurück zum Zitat Luh SP, Chen CY. Video-assisted thoracoscopic surgery (VATS) for the treatment of hepatic hydrothorax: report of twelve cases. J Zhejiang Univ Sci B. 2009;10:547–551.CrossRefPubMedPubMedCentral Luh SP, Chen CY. Video-assisted thoracoscopic surgery (VATS) for the treatment of hepatic hydrothorax: report of twelve cases. J Zhejiang Univ Sci B. 2009;10:547–551.CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Ma SW, Kim HJ, Park JH, et al. Chemical pleurodesis for the management of symptomatic hepatic hydrothroax. J Gastroenterol Hepatol. 2010;25:A20.CrossRef Ma SW, Kim HJ, Park JH, et al. Chemical pleurodesis for the management of symptomatic hepatic hydrothroax. J Gastroenterol Hepatol. 2010;25:A20.CrossRef
61.
Zurück zum Zitat Mitani R, Yabushita K, Morimoto Y, et al. Effective chemical pleurodesis (CP) using non-invasive positive pressure ventilation (NPPV) for refractory hepatic hydrothorax patients. Gastroenterology. 2011;140:S458–S459. Mitani R, Yabushita K, Morimoto Y, et al. Effective chemical pleurodesis (CP) using non-invasive positive pressure ventilation (NPPV) for refractory hepatic hydrothorax patients. Gastroenterology. 2011;140:S458–S459.
62.
Zurück zum Zitat Mouroux J, Perrin C, Venissac N, Blaive B, Richelme H. Management of pleural effusion of cirrhotic origin. Chest. 1996;109:1093–1096.CrossRefPubMed Mouroux J, Perrin C, Venissac N, Blaive B, Richelme H. Management of pleural effusion of cirrhotic origin. Chest. 1996;109:1093–1096.CrossRefPubMed
64.
Zurück zum Zitat Takayama T, Kurokawa Y, Kaiwa Y, et al. A new technique of thoracoscopic pleurodesis for refractory hepatic hydrothorax. Surg Endosc. 2004;18:140–143.CrossRefPubMed Takayama T, Kurokawa Y, Kaiwa Y, et al. A new technique of thoracoscopic pleurodesis for refractory hepatic hydrothorax. Surg Endosc. 2004;18:140–143.CrossRefPubMed
65.
Zurück zum Zitat Vargas FS, Milanez JRC, Filomeno LTB, Fernandez A, Jatene A, Light RW. Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest. 1994;106:1771–1775.CrossRefPubMed Vargas FS, Milanez JRC, Filomeno LTB, Fernandez A, Jatene A, Light RW. Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest. 1994;106:1771–1775.CrossRefPubMed
66.
Zurück zum Zitat Shimbo A, Matsuda S, Tejima K, et al. Induced negative pressure proposed as a new method for diagnosing hepatic hydrothorax involving minor leaks. Clin Case Rep. 2014;2:296–302.CrossRefPubMedPubMedCentral Shimbo A, Matsuda S, Tejima K, et al. Induced negative pressure proposed as a new method for diagnosing hepatic hydrothorax involving minor leaks. Clin Case Rep. 2014;2:296–302.CrossRefPubMedPubMedCentral
Metadaten
Titel
Effectiveness and Safety of Pleurodesis for Hepatic Hydrothorax: A Systematic Review and Meta-Analysis
verfasst von
Feifei Hou
Xingshun Qi
Xiaozhong Guo
Publikationsdatum
25.07.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2016
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4260-9

Weitere Artikel der Ausgabe 11/2016

Digestive Diseases and Sciences 11/2016 Zur Ausgabe

Stanford Multidisciplinary Seminars

Recurrent Pyogenic Cholangitis: Got Stones?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.